aluates Reports

$ 0.0

Automative

Global PTCA Coronary Drug Eluting Balloons Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-27U9241

Global PTCA Coronary Drug Eluting Balloons Market Insights and Forecast to 2028

BUY CHAPTERS

Global PTCA Coronary Drug Eluting Balloons Market Research Report 2025

Code: QYRE-Auto-27U9241

Report

August 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

B. Braun

Spectranetics

Concept Medical

Eurocor GmbH

LifeTech

QualiMed

Acrostak

Maxcor

Micell

PTCA Coronary Drug Eluting Balloons Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

PTCA Coronary Drug Eluting Balloons Market

The global market for PTCA Coronary Drug Eluting Balloons was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PTCA Coronary Drug Eluting Balloons, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PTCA Coronary Drug Eluting Balloons.

The PTCA Coronary Drug Eluting Balloons market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PTCA Coronary Drug Eluting Balloons market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PTCA Coronary Drug Eluting Balloons manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PTCA Coronary Drug Eluting Balloons Market Report

Report Metric	Details
Report Name	PTCA Coronary Drug Eluting Balloons Market
CAGR	5%
Segment by Type	DEB Balloon Standard Balloon
Segment by Application	Small Vessel Disease Bifurcation Lesions Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	B.Braun, Spectranetics, Concept Medical, Eurocor, Lifetech, Maxcor, Micell, Qualimed, Acrostak
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PTCA Coronary Drug Eluting Balloons manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PTCA Coronary Drug Eluting Balloons in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PTCA Coronary Drug Eluting Balloons Market report?

Ans: The main players in the PTCA Coronary Drug Eluting Balloons Market are B.Braun, Spectranetics, Concept Medical, Eurocor, Lifetech, Maxcor, Micell, Qualimed, Acrostak

What are the Application segmentation covered in the PTCA Coronary Drug Eluting Balloons Market report?

Ans: The Applications covered in the PTCA Coronary Drug Eluting Balloons Market report are Small Vessel Disease, Bifurcation Lesions, Others

What are the Type segmentation covered in the PTCA Coronary Drug Eluting Balloons Market report?

Ans: The Types covered in the PTCA Coronary Drug Eluting Balloons Market report are DEB Balloon, Standard Balloon

Recommended Reports

PTCA & Drug Balloons

Coronary & Cardiovascular

Disease & Therapy

1 PTCA Coronary Drug Eluting Balloons Market Overview

1.1 Product Definition

1.2 PTCA Coronary Drug Eluting Balloons by Type

1.2.1 Global PTCA Coronary Drug Eluting Balloons Market Value Comparison by Type (2024 VS 2031)

1.2.2 DEB Balloon

1.2.3 Standard Balloon

1.3 PTCA Coronary Drug Eluting Balloons by Application

1.3.1 Global PTCA Coronary Drug Eluting Balloons Market Value by Application (2024 VS 2031)

1.3.2 Small Vessel Disease

1.3.3 Bifurcation Lesions

1.3.4 Others

1.4 Global PTCA Coronary Drug Eluting Balloons Market Size Estimates and Forecasts

1.4.1 Global PTCA Coronary Drug Eluting Balloons Revenue 2020-2031

1.4.2 Global PTCA Coronary Drug Eluting Balloons Sales 2020-2031

1.4.3 Global PTCA Coronary Drug Eluting Balloons Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 PTCA Coronary Drug Eluting Balloons Market Competition by Manufacturers

2.1 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Manufacturers (2020-2025)

2.2 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Manufacturers (2020-2025)

2.3 Global PTCA Coronary Drug Eluting Balloons Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of PTCA Coronary Drug Eluting Balloons, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Product Type & Application

2.7 Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Date of Enter into This Industry

2.8 Global PTCA Coronary Drug Eluting Balloons Market Competitive Situation and Trends

2.8.1 Global PTCA Coronary Drug Eluting Balloons Market Concentration Rate

2.8.2 The Global 5 and 10 Largest PTCA Coronary Drug Eluting Balloons Players Market Share by Revenue

2.8.3 Global PTCA Coronary Drug Eluting Balloons Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global PTCA Coronary Drug Eluting Balloons Market Scenario by Region

3.1 Global PTCA Coronary Drug Eluting Balloons Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global PTCA Coronary Drug Eluting Balloons Sales by Region: 2020-2031

3.2.1 Global PTCA Coronary Drug Eluting Balloons Sales by Region: 2020-2025

3.2.2 Global PTCA Coronary Drug Eluting Balloons Sales by Region: 2026-2031

3.3 Global PTCA Coronary Drug Eluting Balloons Revenue by Region: 2020-2031

3.3.1 Global PTCA Coronary Drug Eluting Balloons Revenue by Region: 2020-2025

3.3.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Region: 2026-2031

3.4 North America PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country

3.4.1 North America PTCA Coronary Drug Eluting Balloons Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America PTCA Coronary Drug Eluting Balloons Sales by Country (2020-2031)

3.4.3 North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country

3.5.1 Europe PTCA Coronary Drug Eluting Balloons Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2020-2031)

3.5.3 Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Region

3.6.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2020-2031)

3.6.3 Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country

3.7.1 Latin America PTCA Coronary Drug Eluting Balloons Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2020-2031)

3.7.3 Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country

3.8.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2020-2031)

3.8.3 Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global PTCA Coronary Drug Eluting Balloons Sales by Type (2020-2031)

4.1.1 Global PTCA Coronary Drug Eluting Balloons Sales by Type (2020-2025)

4.1.2 Global PTCA Coronary Drug Eluting Balloons Sales by Type (2026-2031)

4.1.3 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2020-2031)

4.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2020-2031)

4.2.1 Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2020-2025)

4.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2026-2031)

4.2.3 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2020-2031)

4.3 Global PTCA Coronary Drug Eluting Balloons Price by Type (2020-2031)

5 Segment by Application

5.1 Global PTCA Coronary Drug Eluting Balloons Sales by Application (2020-2031)

5.1.1 Global PTCA Coronary Drug Eluting Balloons Sales by Application (2020-2025)

5.1.2 Global PTCA Coronary Drug Eluting Balloons Sales by Application (2026-2031)

5.1.3 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2020-2031)

5.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2020-2031)

5.2.1 Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2020-2025)

5.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2026-2031)

5.2.3 Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2020-2031)

5.3 Global PTCA Coronary Drug Eluting Balloons Price by Application (2020-2031)

6 Key Companies Profiled

6.1 B.Braun

6.1.1 B.Braun Company Information

6.1.2 B.Braun Description and Business Overview

6.1.3 B.Braun PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.1.4 B.Braun PTCA Coronary Drug Eluting Balloons Product Portfolio

6.1.5 B.Braun Recent Developments/Updates

6.2 Spectranetics

6.2.1 Spectranetics Company Information

6.2.2 Spectranetics Description and Business Overview

6.2.3 Spectranetics PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Spectranetics PTCA Coronary Drug Eluting Balloons Product Portfolio

6.2.5 Spectranetics Recent Developments/Updates

6.3 Concept Medical

6.3.1 Concept Medical Company Information

6.3.2 Concept Medical Description and Business Overview

6.3.3 Concept Medical PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Concept Medical PTCA Coronary Drug Eluting Balloons Product Portfolio

6.3.5 Concept Medical Recent Developments/Updates

6.4 Eurocor

6.4.1 Eurocor Company Information

6.4.2 Eurocor Description and Business Overview

6.4.3 Eurocor PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Eurocor PTCA Coronary Drug Eluting Balloons Product Portfolio

6.4.5 Eurocor Recent Developments/Updates

6.5 Lifetech

6.5.1 Lifetech Company Information

6.5.2 Lifetech Description and Business Overview

6.5.3 Lifetech PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Lifetech PTCA Coronary Drug Eluting Balloons Product Portfolio

6.5.5 Lifetech Recent Developments/Updates

6.6 Maxcor

6.6.1 Maxcor Company Information

6.6.2 Maxcor Description and Business Overview

6.6.3 Maxcor PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Maxcor PTCA Coronary Drug Eluting Balloons Product Portfolio

6.6.5 Maxcor Recent Developments/Updates

6.7 Micell

6.7.1 Micell Company Information

6.7.2 Micell Description and Business Overview

6.7.3 Micell PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Micell PTCA Coronary Drug Eluting Balloons Product Portfolio

6.7.5 Micell Recent Developments/Updates

6.8 Qualimed

6.8.1 Qualimed Company Information

6.8.2 Qualimed Description and Business Overview

6.8.3 Qualimed PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Qualimed PTCA Coronary Drug Eluting Balloons Product Portfolio

6.8.5 Qualimed Recent Developments/Updates

6.9 Acrostak

6.9.1 Acrostak Company Information

6.9.2 Acrostak Description and Business Overview

6.9.3 Acrostak PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Acrostak PTCA Coronary Drug Eluting Balloons Product Portfolio

6.9.5 Acrostak Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 PTCA Coronary Drug Eluting Balloons Industry Chain Analysis

7.2 PTCA Coronary Drug Eluting Balloons Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 PTCA Coronary Drug Eluting Balloons Production Mode & Process Analysis

7.4 PTCA Coronary Drug Eluting Balloons Sales and Marketing

7.4.1 PTCA Coronary Drug Eluting Balloons Sales Channels

7.4.2 PTCA Coronary Drug Eluting Balloons Distributors

7.5 PTCA Coronary Drug Eluting Balloons Customer Analysis

8 PTCA Coronary Drug Eluting Balloons Market Dynamics

8.1 PTCA Coronary Drug Eluting Balloons Industry Trends

8.2 PTCA Coronary Drug Eluting Balloons Market Drivers

8.3 PTCA Coronary Drug Eluting Balloons Market Challenges

8.4 PTCA Coronary Drug Eluting Balloons Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

B. Braun

Spectranetics

Concept Medical

Eurocor GmbH

LifeTech

QualiMed

Acrostak

Maxcor

Micell

List of Tables

Table 1. Global PTCA Coronary Drug Eluting Balloons Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global PTCA Coronary Drug Eluting Balloons Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global PTCA Coronary Drug Eluting Balloons Market Competitive Situation by Manufacturers in 2024

Table 4. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Manufacturers (2020-2025)

Table 6. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market PTCA Coronary Drug Eluting Balloons Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of PTCA Coronary Drug Eluting Balloons, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Product Type & Application

Table 12. Global Key Manufacturers of PTCA Coronary Drug Eluting Balloons, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global PTCA Coronary Drug Eluting Balloons by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PTCA Coronary Drug Eluting Balloons as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global PTCA Coronary Drug Eluting Balloons Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global PTCA Coronary Drug Eluting Balloons Sales by Region (2020-2025) & (K Units)

Table 18. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2020-2025)

Table 19. Global PTCA Coronary Drug Eluting Balloons Sales by Region (2026-2031) & (K Units)

Table 20. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2026-2031)

Table 21. Global PTCA Coronary Drug Eluting Balloons Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2020-2025)

Table 23. Global PTCA Coronary Drug Eluting Balloons Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2026-2031)

Table 25. North America PTCA Coronary Drug Eluting Balloons Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America PTCA Coronary Drug Eluting Balloons Sales by Country (2020-2025) & (K Units)

Table 27. North America PTCA Coronary Drug Eluting Balloons Sales by Country (2026-2031) & (K Units)

Table 28. North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2020-2025) & (K Units)

Table 32. Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2026-2031) & (K Units)

Table 33. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2020-2025) & (K Units)

Table 42. Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2026-2031) & (K Units)

Table 43. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) by Type (2020-2025)

Table 51. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) by Type (2026-2031)

Table 52. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2020-2025)

Table 53. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2026-2031)

Table 54. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Type (2020-2025)

Table 55. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Type (2026-2031)

Table 56. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2020-2025)

Table 57. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2026-2031)

Table 58. Global PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Type (2020-2025)

Table 59. Global PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Type (2026-2031)

Table 60. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) by Application (2020-2025)

Table 61. Global PTCA Coronary Drug Eluting Balloons Sales (K Units) by Application (2026-2031)

Table 62. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2020-2025)

Table 63. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2026-2031)

Table 64. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Application (2020-2025)

Table 65. Global PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Application (2026-2031)

Table 66. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2020-2025)

Table 67. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2026-2031)

Table 68. Global PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Application (2020-2025)

Table 69. Global PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Application (2026-2031)

Table 70. B.Braun Company Information

Table 71. B.Braun Description and Business Overview

Table 72. B.Braun PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. B.Braun PTCA Coronary Drug Eluting Balloons Product

Table 74. B.Braun Recent Developments/Updates

Table 75. Spectranetics Company Information

Table 76. Spectranetics Description and Business Overview

Table 77. Spectranetics PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Spectranetics PTCA Coronary Drug Eluting Balloons Product

Table 79. Spectranetics Recent Developments/Updates

Table 80. Concept Medical Company Information

Table 81. Concept Medical Description and Business Overview

Table 82. Concept Medical PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Concept Medical PTCA Coronary Drug Eluting Balloons Product

Table 84. Concept Medical Recent Developments/Updates

Table 85. Eurocor Company Information

Table 86. Eurocor Description and Business Overview

Table 87. Eurocor PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Eurocor PTCA Coronary Drug Eluting Balloons Product

Table 89. Eurocor Recent Developments/Updates

Table 90. Lifetech Company Information

Table 91. Lifetech Description and Business Overview

Table 92. Lifetech PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Lifetech PTCA Coronary Drug Eluting Balloons Product

Table 94. Lifetech Recent Developments/Updates

Table 95. Maxcor Company Information

Table 96. Maxcor Description and Business Overview

Table 97. Maxcor PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Maxcor PTCA Coronary Drug Eluting Balloons Product

Table 99. Maxcor Recent Developments/Updates

Table 100. Micell Company Information

Table 101. Micell Description and Business Overview

Table 102. Micell PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Micell PTCA Coronary Drug Eluting Balloons Product

Table 104. Micell Recent Developments/Updates

Table 105. Qualimed Company Information

Table 106. Qualimed Description and Business Overview

Table 107. Qualimed PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Qualimed PTCA Coronary Drug Eluting Balloons Product

Table 109. Qualimed Recent Developments/Updates

Table 110. Acrostak Company Information

Table 111. Acrostak Description and Business Overview

Table 112. Acrostak PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Acrostak PTCA Coronary Drug Eluting Balloons Product

Table 114. Acrostak Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. PTCA Coronary Drug Eluting Balloons Distributors List

Table 118. PTCA Coronary Drug Eluting Balloons Customers List

Table 119. PTCA Coronary Drug Eluting Balloons Market Trends

Table 120. PTCA Coronary Drug Eluting Balloons Market Drivers

Table 121. PTCA Coronary Drug Eluting Balloons Market Challenges

Table 122. PTCA Coronary Drug Eluting Balloons Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of PTCA Coronary Drug Eluting Balloons

Figure 2. Global PTCA Coronary Drug Eluting Balloons Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global PTCA Coronary Drug Eluting Balloons Market Share by Type: 2024 & 2031

Figure 4. DEB Balloon Product Picture

Figure 5. Standard Balloon Product Picture

Figure 6. Global PTCA Coronary Drug Eluting Balloons Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global PTCA Coronary Drug Eluting Balloons Market Share by Application: 2024 & 2031

Figure 8. Small Vessel Disease

Figure 9. Bifurcation Lesions

Figure 10. Others

Figure 11. Global PTCA Coronary Drug Eluting Balloons Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global PTCA Coronary Drug Eluting Balloons Market Size (2020-2031) & (US$ Million)

Figure 13. Global PTCA Coronary Drug Eluting Balloons Sales (2020-2031) & (K Units)

Figure 14. Global PTCA Coronary Drug Eluting Balloons Average Price (USD/Unit) & (2020-2031)

Figure 15. PTCA Coronary Drug Eluting Balloons Report Years Considered

Figure 16. PTCA Coronary Drug Eluting Balloons Sales Share by Manufacturers in 2024

Figure 17. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest PTCA Coronary Drug Eluting Balloons Players: Market Share by Revenue in PTCA Coronary Drug Eluting Balloons in 2024

Figure 19. PTCA Coronary Drug Eluting Balloons Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global PTCA Coronary Drug Eluting Balloons Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2020-2031)

Figure 22. North America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2020-2031)

Figure 23. U.S. PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2020-2031)

Figure 26. Europe PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2020-2031)

Figure 27. Germany PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2020-2031)

Figure 34. China PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2020-2031)

Figure 45. Latin America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2020-2031)

Figure 46. Mexico PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2020-2031)

Figure 51. Turkey PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of PTCA Coronary Drug Eluting Balloons by Type (2020-2031)

Figure 55. Global Revenue Market Share of PTCA Coronary Drug Eluting Balloons by Type (2020-2031)

Figure 56. Global PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of PTCA Coronary Drug Eluting Balloons by Application (2020-2031)

Figure 58. Global Revenue Market Share of PTCA Coronary Drug Eluting Balloons by Application (2020-2031)

Figure 59. Global PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Application (2020-2031)

Figure 60. PTCA Coronary Drug Eluting Balloons Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Coated Balloons Market Insights Forecast to 2030

Coronary Intervention Drug Eluting Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug coated Balloon Dilatation Catheters Market Research Report 2025

Global Drug eluting PTA Balloon Dilatation Catheter Market Research Report 2025

Global Intracranial Drug Eluting Stents Market Research Report 2024

Global PTCA Coronary Balloon Catheter Market Research Report 2025

Global Coronary Artery Disease Treatment Devices Market Research Report 2025

Drug Eluting Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coronary PTCA Balloon Dilatation Catheters Market Research Report 2025

Drug Coated Balloon DCB Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ureteral Dilation Balloon Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pulmonary Embolism Drug Market Research Report 2025

Cardiac Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PTCA Dilatation Balloon Catheters Market Research Report 2025

Cardiovascular Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Coated PTA Balloon Catheter Market Research Report 2024

Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Myocardial Infarction Drug Market Research Report 2024

Cardiovascular Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16G6108

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27Q5892

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14K19926

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15N17310

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions